Does lisinopril improve systemic extracellular degradation of collagen type I in patients with essential hypertension?
Patients with essential hypertension
Lisinopril
Systemic extracellular degradation of collagen type Isurrogate
Lisinopril normalizes depressed systemic extracellular degradation of collagen type I in patients with essential hypertension, which may help prevent organ fibrosis and left ventricular hypertrophy.
These findings suggest that systemic extracellular degradation of collagen type I is depressed in patients with essential hypertension and can be normalized by treatment with lisinopril. A depressed degradation of collagen type I may facilitate organ fibrosis in hypertensive patients, namely, in those with left ventricular hypertrophy.
Building similarity graph...
Analyzing shared references across papers
Loading...
Concepción Laviades
Nerea Varo
Javier Fernández
Circulation
Hospital General San Jorge
Building similarity graph...
Analyzing shared references across papers
Loading...
Laviades et al. (Tue,) studied this question.
www.synapsesocial.com/papers/69d56c3d75589c71d767cd1b — DOI: https://doi.org/10.1161/01.cir.98.6.535